3 unknown, 1 completed. 2 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Cerebral Atherosclerosis: new trials by email Literature Review of Cerebral Atherosclerosis trials Research Report on Cerebral Atherosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study Evolocumab 140 MG/ML, Intensive statin treatment - Cerebral Atherosclerosis | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 200 | 2022-11-09 | 2023-12-11 |
| DEB for Symptomatic Intracranial Atherosclerosis Stenosis Drug eluting balloon (Vmoky) - Cerebral Ischemia, Cerebral Atherosclerosis | Not applicable | Unknown | Yinyi(Liaoning) Biotech Co., Ltd. | 155 | 2021-06-21 | 2023-01-31 |
| Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning Doctormate®+Medical Management, Medical Management - Cerebral Atherosclerosis | Not applicable | Unknown | Ji Xunming,MD,PhD | 700 | 2020-09-01 | 2020-07-14 |
| Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis Divaza, Placebo - Cerebral Atherosclerosis | Phase 4 | Completed | Materia Medica Holding | 124 | 2018-04-12 | 2021-08-26 |
Intracranial Arteriosclerosis (4) · Atherosclerosis (1) · Brain Ischemia (1) · Ischemic Stroke (1)
Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Brain Diseases (4) · Cardiovascular Diseases (4) · Central Nervous System Diseases (4) · Cerebrovascular Disorders (4) · Intracranial Arterial Diseases (4) · Nervous System Diseases (4) · Vascular Diseases (4) · Stroke (1)
Practice Management, Medical (1) · divaza (1) · evolocumab (1)
Ji Xunming,MD,PhD (1) · Materia Medica Holding (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Yinyi(Liaoning) Biotech Co., Ltd. (1)
China (2) · Russia (1)
Bo Hu, Doctor (1) · Candong Hong, Doctor (1) · Jiehong Wu, Doctor (1) · Lei Zhang, Doctor (1) · Quanwei He, Doctor (1) · Tianxiao Li (1) · Xunming Ji, MD.PhD (1)